# Safety and Effects of Implanted (Autologous) Skeletal Myoblasts (MyoCell) Using an Injection Catheter = SEISMIC Trial

> **NCT00375817** · PHASE2 · UNKNOWN · sponsor: **Bioheart, Inc.** · enrollment: 40 (actual)

## Conditions studied

- Myocardial Infarction
- Heart Failure, Congestive

## Interventions

- **PROCEDURE:** Myoblasts injection with MyoCath catheter

## Key facts

- **NCT ID:** NCT00375817
- **Lead sponsor:** Bioheart, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-11
- **Primary completion:** —
- **Final completion:** 2008-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2007-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00375817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00375817, "Safety and Effects of Implanted (Autologous) Skeletal Myoblasts (MyoCell) Using an Injection Catheter = SEISMIC Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00375817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*